Dr. Tony Philip, MD

Dr. Philip practices at Long Island Jewish Medical Center in New Hyde Park, New York.

Dr. Philip's NPI, 1174772982, was assigned on September 17, 2008. Dr. Philip graduated from University at Buffalo School of Medicine in 2005. Dr. Philip holds New York license 247433.

Dr. Philip's primary practice is Long Island Jewish Medical Center, at 27005 76th Ave, New Hyde Park, NY 11040 in Nassau County. The practice phone is (516) 876-6000.

Dr. Philip's primary practice is Long Island Jewish Medical Center in New Hyde Park, New York. Dr. Philip is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Philip to 1 more hospital, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Philip practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Philip's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Philip is board certified in hematology by the American Board of Internal Medicine. Dr. Philip is licensed in New York.

CMS data shows 731 Medicare services from Dr. Philip across 6 procedure codes in 2024, for 199 Medicare patients. Medicare paid $61,800 for them.

CMS counts 199 Medicare patients who saw Dr. Philip in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Philip's median patient age at 70, with 48% women.

In 2024, Dr. Philip wrote 242 Medicare Part D claims for 51 patients. 81% of them were for generic drugs. CMS names the drug for 152 of them, across 3 drugs with 11 or more claims each, at $452,086 in total drug cost. In 2023, CMS named 108 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Philip for performance year 2024, reported as part of a group. Dr. Philip accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Philip as offering telehealth.

Dmand AI links 4 papers to Dr. Philip, published from 2016 to 2025. The most frequent topics are Rectal Neoplasms. Dr. Philip's most frequent co-authors are Allison Marian Magnuson, DO, Eric David Miller, MD, PhD and Supriya Gupta Mohile, MD.

Dmand AI links Dr. Philip to 9 clinical trials, 3 of them phase 2/3 studies. 2 are still active or recruiting. Conditions studied include Sarcoma, Neoplasms, Connective and Soft Tissue and Adenocarcinoma Of Esophagus. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Philip that name 2 trials.

CMS Open Payments shows 70 general payments to Dr. Philip from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $24,106. It also lists 3 research payments totaling $3,545 from 2016 to 2018, naming 2 clinical trials.

Dr. Philip graduated from University at Buffalo School of Medicine in 2005.